NO(3) can be stabilized in solid neon either by codeposition at 4.3 K of a Ne:O(2) mixture with a Ne:NO mixture that has been passed through a microwave discharge or, in higher yield, by codeposition of a Ne:NO mixture with a Ne:O(2) mixture, followed by annealing of the deposit at approximately 7 K and exposure of the solid to near ultraviolet radiation. All of the previously reported bands of NO(3) between 700 and 3000 cm(-1) were observed, most with neon-matrix shifts of less than 2.5 cm(-1). The infrared spectra of eight isotopic species of NO(3) were obtained. The observed isotopic shifts demonstrate the occurrence of extensive mixing of ground-state levels of e(') symmetry and their strong vibronic interaction with the B (2)E(') state. Photodissociation of NO(3) by irradiation of the deposit at wavelengths longer than 520 nm leads to new absorptions near the fundamentals of NO and O(2) and other new absorptions at relatively low frequencies. These absorptions were depleted and NO(3) regenerated by subsequent near ultraviolet irradiation of the deposit, suggesting the stabilization of a weakly bound NO(O(2)) complex in solid neon.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1063/1.3020753 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Phase I study of BMS-986299, an NLRP3 agonist, as monotherapy and in combination with nivolumab and ipilimumab in patients with advanced solid tumors.
J Immunother Cancer
January 2025
Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Purpose: BMS-986299 is a first-in-class, NOD-, LRR-, and pyrin-domain containing-3 (NLRP3) inflammasome agonist enhancing adaptive immune and T-cell memory responses.
Materials And Methods: This was a phase-I (NCT03444753) study that assessed the safety and tolerability of intra-tumoral BMS-986299 monotherapy (part 1A) and in combination (part 1B) with nivolumab, and ipilimumab in advanced solid tumors. Reported here are single-center results.
Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial.
Nat Med
January 2025
Department of Medicine-Medical Oncology, University of Colorado Cancer Center, Denver, CO, USA.
Effective targeting of somatic cancer mutations to enhance the efficacy of cancer immunotherapy requires an individualized approach. Autogene cevumeran is a uridine messenger RNA lipoplex-based individualized neoantigen-specific immunotherapy designed from tumor-specific somatic mutation data obtained from tumor tissue of each individual patient to stimulate T cell responses against up to 20 neoantigens. This ongoing phase 1 study evaluated autogene cevumeran as monotherapy (n = 30) and in combination with atezolizumab (n = 183) in pretreated patients with advanced solid tumors.
View Article and Find Full Text PDFBackground: Belzutifan, a first-in-class HIF-2α inhibitor, has shown antitumour activity as monotherapy and in combination with cabozantinib in patients with previously treated advanced kidney cancer. The phase 2 LITESPARK-003 study was designed to determine the antitumour activity and safety of belzutifan in combination with cabozantinib in patients with advanced clear-cell renal cell carcinoma that was previously untreated (cohort 1) or previously treated with immunotherapy (cohort 2). Here, we report results from cohort 1 of this clinical trial.
View Article and Find Full Text PDFMeasurement of the Spin Polarization of a Slow Positron Beam Using Circularly Polarized Microwave Radiation.
Phys Rev Lett
December 2024
Department of Physics and Astronomy, University College London, Gower Street, London WC1E 6BT, United Kingdom.
We have measured the spin polarization of a slow positron beam via state-selective depopulation of 2^{3}S_{1} positronium atoms, generated by passing the beam through a gas cell. Our method employs circularly polarized microwave radiation to drive 2^{3}S_{1}→2^{3}P_{1} transitions, for which either Δm_{J}=+1 or Δm_{J}=-1, and relies on the fact that asymmetries between the two cases yield the underlying positron beam polarization. Using this technique we show that the polarization of a positron beam derived from a solid neon moderator may be increased from 30% to 90% by increasing the moderator thickness, with an associated reduction in beam intensity of 60%.
View Article and Find Full Text PDFHow Vibrational Notations Can Spoil Infrared Spectroscopy: A Case Study on Isolated Methanol.
ACS Phys Chem Au
November 2024
Department of General, Inorganic and Theoretical Chemistry, University of Innsbruck, Innrain 80, Innsbruck 6020, Austria.
Unraveling methanol's infrared spectrum has challenged spectroscopists for a century, with numerous loose ends still to be explored. We engage in this exploration based on experiments of isolating single methanol molecules in solid argon and neon matrices. We report infrared spectra of methanol in its natural isotopic composition and with partial and full deuteration.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!